Pharmabiz

Peer-reviewed publication in Clinical & Experimental Allergy reveals potential disease-modifying effect of Mabylon’s allergen-neutralizing antibodies

Peer-reviewed publication in Clinical & Experimental Allergy reveals potential disease-modifying effect of Mabylon’s allergen-neutralizing antibodies: Zurich, Switzerland Thursd ...
Pharmabiz

Apollo Hospitals in Q2 clocks 23% rise in revenue at Rs. 7,615 crore, PAT increases to 32% at Rs. 630 crore

Apollo Hospitals in Q2 clocks 23% rise in revenue at Rs. 7,615 crore, PAT increases to 32% at Rs. 630 crore: Our Bureau, Bengaluru Thursday, November 5, 2026, 14:30 Hrs [IST] Apol ...
Pharmabiz

Signant Health introduces Signant SignalSpace, a connected environment for clinical trial data and workflows

Signant Health introduces Signant SignalSpace, a connected environment for clinical trial data and workflows: Philadelphia Thursday, November 5, 2026, 16:00 Hrs [IST] Signant Heal ...
Pharmabiz

Aurobindo Pharma Q2 revenue from operations up 24%

Aurobindo Pharma Limited announced its consolidated financial results for the quarter ended September 30, 2026. The company's revenue from operations stood at Rs. 10,263 crore, reporting an increase ...
Pharmabiz

START expands its global early phase cancer site network into Italy through strategic partnership with Istituti Fisioterapici Ospitalieri

START expands its global early phase cancer site network into Italy through strategic partnership with Istituti Fisioterapici Ospitalieri: San Antonio, Texas Thursday, November 5, ...
Pharmabiz

Ennature Bio Pharma lists on NSE and BSE on 4th November, 2026

Ennature Bio Pharma lists on NSE and BSE on 4th November, 2026: Our Bureau, Bengaluru Thursday, November 5, 2026, 14:15 Hrs [IST] Ennature Bio Pharma listed on the National Stock ...
Pharmabiz

Pfizer appoints Cecile Guegan as chief financial officer & executive vice president

Pfizer appoints Cecile Guegan as chief financial officer & executive vice president: New York Thursday, November 5, 2026, ...
Pharmabiz

India-based Taisho Ventures receives DBS Foundation Impact Beyond Award to advance active ageing

India-based Taisho Ventures receives DBS Foundation Impact Beyond Award to advance active ageing: Our Bureau, Bengaluru Thursday, November 5, 2026, 11:30 Hrs [IST] DBS Foundation ...
Pharmabiz

IMA, API, and 5 medical bodies join UN:BLOC at ‘Clinicians of the Future’ to discuss the AI in healthcare

BLOC at ‘Clinicians of the Future’ to discuss the AI in healthcare: Our Bureau, Bengaluru Thursday, November 5, 2026, 11:15 Hrs [IST] Th ...
Pharmabiz

Merck begins phase 3 study of Ohtuvayre for prevention of COPD exacerbations in adult patients receiving standard of care with a history of exacerbations

Merck begins phase 3 study of Ohtuvayre for prevention of COPD exacerbations in adult patients receiving standard of care with a history of exacerbations: Rahway, New Jersey Thurs ...
Pharmabiz

Shilpa CDMO to invest $50 million in commercial peptide manufacturing

Shilpa CDMO to invest $50 million in commercial peptide manufacturing: Our Bureau, Bengaluru Thursday, November 5, 2026, 10:45 Hrs [IST] Shilpa, the complex chemistry CDMO, is inv ...
Pharmabiz

Boehringer Ingelheim and Sino Biopharmaceutical ink partnership to advance next-generation cancer therapies

Boehringer Ingelheim and Sino Biopharmaceutical ink partnership to advance next-generation cancer therapies: Ingelheim, Germany Thursday, November 5, 2026, 10:00 Hrs [IST] Boehrin ...